Skip to main content
OpenTrials
Completed

NCT Number: NCT05018065

Sexual Functions and Covid-19

Sexual health is one the important components of life quality. The aim of this study is to compare sexual dysfunction of women who survived Covid-19 and who didn't undergo Covid-19.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 Behavior COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Sexual Behavior Virus Diseases

Age range

30 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Saglık Bilimleri University Istanbul Gaziosmanpa Trainig and Research Hospital

Istanbul, Turkey (Türkiye)

About this study

With identifying a new type of coronavirus, the infection disease known as Coronavirus disease-2019 (Covid-19) is still effective worldwide. Within the frame of the description that the health is "a complete physical, mental and social welfare," many physical and mental modality may be expected due to the pandemic and the measures against pandemic. Among them, sexual health is one of the basic indicative factors of human welfare. There are few data on sexual dysfunctions from the previous clinic pandemic experiences. From the very early stages of Covid-19 pandemic, health systems and researches focused on mortalities and short-term morbidities. Although there are similar studies about effects of pandemic on sexual behaviors of general community, there is no comparative study about the effects on sexual functions of women survived from Covid-19 and women having no Covid-19 history, yet. This study aims to compare women survived from Covid-19 and women having no Covid-19 history and having similar characteristics in terms of sexual dysfunctions.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • previously diagnosed for mild - medium Covid-19 infection and had ambulatory care
  • being sexually active

Exclusion criteria

  • having psychiatric disease
  • having any malignity
  • having endometriosis
  • having a gynecologic surgery history
  • having a previous sexual dysfunction

Treatment and study plan

Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)

Behavioral

sexual dysfunction assesment

Primary outcomes

  1. Sexual function assesment of women previously diagnosed with mild - medium Covid-19 and comparision of results with helath women

    Time frame: 6 months

    Sexual function assesment of women is done by using Female Sexual Functioning Index (FSFI).

Sponsors and collaborators

Lead sponsor

Gaziosmanpasa Research and Education Hospital

Other Gov

Registry information

Official study title

Evaluation of Women's Sexual Functions After Having Covid-19

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Aug 24, 2021
Registry last updated
Aug 27, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.